CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
80.98
+2.62 (3.34%)
At close: Apr 28, 2026, 4:00 PM EDT
81.09
+0.11 (0.14%)
After-hours: Apr 28, 2026, 5:27 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for CVS Health stock have an average target of 94.72, with a low estimate of 80 and a high estimate of 102. The average target predicts an increase of 16.97% from the current stock price of 80.98.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 8 | 8 | 7 | 7 |
| Buy | 11 | 11 | 10 | 10 | 11 | 11 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 18 | 19 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $92 → $94 | Buy | Maintains | $92 → $94 | +16.08% | Apr 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $101 → $99 | Buy | Maintains | $101 → $99 | +22.25% | Mar 31, 2026 |
| Bernstein | Bernstein | Hold → Buy Upgrades $91 → $94 | Hold → Buy | Upgrades | $91 → $94 | +16.08% | Mar 12, 2026 |
| Argus Research | Argus Research | Strong Buy Maintains $91 → $90 | Strong Buy | Maintains | $91 → $90 | +11.14% | Jan 28, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $100 → $95 | Strong Buy | Maintains | $100 → $95 | +17.31% | Jan 27, 2026 |
Financial Forecast
Revenue This Year
409.25B
from 399.83B
Increased by 2.36%
Revenue Next Year
428.45B
from 409.25B
Increased by 4.69%
EPS This Year
7.24
from 1.39
Increased by 420.85%
EPS Next Year
8.26
from 7.24
Increased by 14.05%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 450.4B | 468.4B | ||||||
| Avg | 409.3B | 428.5B | ||||||
| Low | 388.2B | 400.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 12.6% | 14.4% | ||||||
| Avg | 2.4% | 4.7% | ||||||
| Low | -2.9% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 7.77 | 9.24 | ||||||
| Avg | 7.24 | 8.26 | ||||||
| Low | 6.83 | 7.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 459.0% | 27.6% | ||||||
| Avg | 420.9% | 14.1% | ||||||
| Low | 391.4% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.